Do aromatase inhibitors have adverse effects on cognitive function? - Wikidata - awgldk - TriplyDB

Do aromatase inhibitors have adverse effects on cognitive function?

Do aromatase inhibitors have adverse effects on cognitive function?

http://www.wikidata.org/entity/Q35029513

about

He hears, she hears: are there sex differences in auditory processing?Aromatase inhibitors in pediatrics.Learning and memory performance in a cohort of clinically referred breast cancer survivors: the role of attention versus forgetting in patient-reported memory complaints.Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer.Brain endogenous estrogen levels determine responses to estrogen replacement therapy via regulation of BACE1 and NEP in female Alzheimer's transgenic mice.Adjuvant ovarian function suppression and cognitive function in women with breast cancer.Cognitive impairment following hormone therapy: current opinion of research in breast and prostate cancer patients.Sex Hormones and Cognition: Neuroendocrine Influences on Memory and Learning.Sex-dependent effects of letrozole on anxiety in middle-aged rats.Postmenopausal women with DCIS post-mastectomy: a potential role for aromatase inhibitors.Sexually Dimorphic Effects of Aromatase on Neurobehavioral Responses

P2860

Q28650072-DBDA8499-8884-44B6-9159-048279714144 Q34227175-E0739F95-DD24-44C0-BE0E-E3E9293927EA Q35933336-8655996B-9733-4133-BA4A-0247C201CDD5 Q35949546-544403AD-B5CD-4628-BE73-243E7830DE2A Q36650676-6768C682-9410-41DF-902D-546BD056740A Q37175081-B5EF78A6-418A-4548-8B6B-284457139F1E Q38786134-2FD1B52F-A60C-4376-8BFE-7217668DFA26 Q38878236-AF64A309-DB4E-4BDF-8F47-A8E2C7326F4F Q47888820-8BC033D9-1E51-464B-9B18-DDCEA28DB817 Q50938248-F724871A-8319-4B29-8826-78EF4F6D6488 Q58122135-002497D3-36AA-4F39-83D1-EFA727BA7261

P2860

Do aromatase inhibitors have adverse effects on cognitive function?

http://www.wikidata.org/entity/Q35029513

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Do aromatase inhibitors have adverse effects on cognitive function?

@ast

Do aromatase inhibitors have adverse effects on cognitive function?

@en

type

label

Do aromatase inhibitors have adverse effects on cognitive function?

@ast

Do aromatase inhibitors have adverse effects on cognitive function?

@en

prefLabel

Do aromatase inhibitors have adverse effects on cognitive function?

@ast

Do aromatase inhibitors have adverse effects on cognitive function?

@en

P1433

Q35029513-3D5B940D-AAE0-4FD7-A81B-FF1665C72147

P1476

Q35029513-DA42977F-94E7-43B4-B378-B561EED7886C

P2093

Q35029513-4E26C744-A191-4D19-8AEF-B134DDE41650

Q35029513-8DED84C5-1E39-451B-A4FA-8C509FA369DF

Q35029513-C28AC87B-B30D-4F45-9528-F47692ADD436

P2860

Q35029513-0441297F-78BE-4C61-8732-B0CC1B2D2D60

Q35029513-04E450D1-08F5-459E-9AB4-34FB071BB4AC

Q35029513-0FDFE095-6EA5-453D-8843-78F3C71F92B7

Q35029513-15AF219C-FEE9-4A68-B18F-EA61A1E75899

Q35029513-17952954-35A1-45F9-81FF-EECD18FC4C2F

Q35029513-17FA8F15-8711-4870-89ED-FF293EC53FAE

Q35029513-18351B0D-FF75-4742-BA5E-F544D162FF5B

Q35029513-1B580086-AE2E-4DEC-9897-A19DA0BE89C3

Q35029513-1DAEB7E6-C504-47BE-8563-FF57ADE47B8F

Q35029513-1E8FE919-FB2C-419A-9E27-2E0DC5A43468

P2888

Q35029513-6FADDB2D-C91F-45E0-9D06-2757EA669012

P304

Q35029513-B17D039D-483C-4320-9955-04982A8124D9

P31

Q35029513-24BE7BB9-144A-424A-835A-793E3B6DEFC1

Q35029513-F02635FD-B7EB-4D09-B467-F66EFF5BADA6

P356

Q35029513-4AAFEC7D-07D0-4F74-93A3-FFBAF09CE51D

P433

Q35029513-2120DB24-387B-4FCC-B146-227D845D7D1C

P478

Q35029513-866AD3D4-794D-402D-923C-551A4961D33B

P577

Q35029513-0391A9A4-DFDF-4E77-8E52-C6DB43235A26

P5875

Q35029513-93765CF0-17E2-4D15-9D59-F984F07A41EA

P6179

Q35029513-9BADB502-9FF9-47B1-9EB5-2400BE9CE190

P698

Q35029513-2C17735D-865C-4D53-A6A5-D6AE766B6476

P921

Q35029513-58090DE4-4077-4971-8D02-7648FD58969A

Q35029513-7D4FF06E-849E-4FCF-888E-6F2BA2CFA274

Q35029513-BD435766-FC23-4404-99E8-B729F0CBE5F5

Q35029513-BDC1E2FB-1848-48DE-8723-1B1BCC8533CF

Q35029513-D26042E5-DF59-45EF-8902-61B09A698B8E

P932

Q35029513-220AD264-AD7F-433F-91B3-FEBD3B934A08

P356

P1433

Breast Cancer Research

P1476

Do aromatase inhibitors have adverse effects on cognitive function?

@en

P2093

Karin Ribi

http://www.w3.org/2001/XMLSchema#string

Kelly Anne Phillips

http://www.w3.org/2001/XMLSchema#string

Richard Fisher

http://www.w3.org/2001/XMLSchema#string

P2860

Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer

Clinical trial update: International Breast Cancer Study Group

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.

Oophorectomy, menopause, estrogen, and cognitive aging: the timing hypothesis

Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial.

Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice.

Dose and temporal pattern of estrogen exposure determines neuroprotective outcome in hippocampal neurons: therapeutic implications.

Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats.

P2888

P304

203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR2806

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50362784

http://www.w3.org/2001/XMLSchema#string

P6179

1005599690

http://www.w3.org/2001/XMLSchema#string

P698

21392408

http://www.w3.org/2001/XMLSchema#string

P921

hormone antagonist

cognitive disorder

mechanism of action

breast neoplasm

P932

3109568

http://www.w3.org/2001/XMLSchema#string